FDA panel approves expanded use of peptides in compounding pharmacies, raising concerns about prescription surge in billion-dollar industry.Unusual Whales·1 day ago, 05:24 PMIXJ+0.60%BBH-0.23%
Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoringbenzinga_article·Jul 21 at 01:52 PMTEM-7.22%PSNL-3.60%
Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision MedicineUnusual Whales·Jul 22 at 07:37 AMTEM-7.22%TEMT-13.86%
Tempus AI (TEM) Drops on $1.7B Personalis Deal; Needham Analyst Calls the Slide a "Market Misread"Tip Ranks·Jul 20 at 03:18 PMPSNL-3.60%TEM-7.22%
TEM: $1.5B acquisition combines MRD portfolios to drive growth, data synergies, and profitability by 2027Quartr·Jul 20 at 11:20 AMPSNL-3.60%TEM-7.22%
TEM: A $1.5B acquisition merges AI oncology and MRD tech to lead in cancer monitoringQuartr·Jul 20 at 07:36 AMTEM-7.22%TEMT-13.86%
Tempus AI agrees to buy Personalis for USD 16.25 per share in USD 1.5 billion dealPUBT·Jul 20 at 07:32 AMPSNL-3.60%TEM-7.22%
New AI ETF Bets on Healthcare's $9 Trillion Opportunitybenzinga_article·1 day ago, 02:08 PMHLTH-1.06%CYTK-1.44%
Hsbc Holdings PLC Makes New Investment in 10x Genomics $TXGMarket Beat·2 days ago, 03:50 AMTXG-3.72%HSBA
Benzinga Bulls and Bears: IBM, Super Micro, Teslabenzinga_article·1 day ago, 07:00 AMTSL-2.47%XE-8.54%
Cathie Wood's Ark Bets Big on Mark Zuckerberg, Elon Musk as It Loads Up on Meta and SpaceX — Trims AMD and Robinhoodbenzinga_article·Jul 20 at 10:05 PMSHOP+1.56%AMD-3.29%
President sets import tariffs after 2-year grace period for medicinesFOX Business·Jul 21 at 09:11 PMBIS+1.21%SBIO-0.88%
Pre-market hot trades in US stocks: Tempus AI pre-market down 7.59%, concerns over the acquisition of PersonalisPrice Alert·Jul 20 at 07:37 AMTEM-7.22%
Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health ServiceUnusual Whales·Jul 16 at 07:38 AMTEM-7.22%TEMT-13.86%
